Farallon-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
135
Total Value
17935796589
Accession Number
0000908834-25-000177
Form Type
13F-HR
Manager Name
Farallon-Capital-Management
Data Enrichment
87% identified
118 identified17 unidentified

Holdings

135 positions • $17.9B total value
Manager:
Search and click to pin securities to the top
Tectonic Therapeutic, Inc.
Shares:853.0K
Value:$15.1M
% of Portfolio:0.1% ($15.1M/$17.9B)
ENANTA PHARMACEUTICALS INC
Shares:2.1M
Value:$11.7M
% of Portfolio:0.1% ($11.7M/$17.9B)
Nuvalent, Inc.
Shares:150.0K
Value:$10.6M
% of Portfolio:0.1% ($10.6M/$17.9B)
Tyra Biosciences, Inc.
Shares:1.1M
Value:$10.6M
% of Portfolio:0.1% ($10.6M/$17.9B)
MARA Holdings, Inc.
Shares:835.0K
Value:$9.6M
% of Portfolio:0.1% ($9.6M/$17.9B)
Voyager Therapeutics, Inc.
Shares:2.6M
Value:$8.7M
% of Portfolio:0.0% ($8.7M/$17.9B)
G4444H101
Shares:600.0K
Value:$6.8M
% of Portfolio:0.0% ($6.8M/$17.9B)
Tango Therapeutics, Inc.
Shares:4.6M
Value:$6.3M
% of Portfolio:0.0% ($6.3M/$17.9B)
GLOBUS MEDICAL INC
Shares:83.0K
Value:$6.1M
% of Portfolio:0.0% ($6.1M/$17.9B)
SpringWorks Therapeutics, Inc.
Shares:118.0K
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$17.9B)
Zymeworks Inc.
Shares:400.0K
Value:$4.8M
% of Portfolio:0.0% ($4.8M/$17.9B)
RxSight, Inc.
Shares:175.0K
Value:$4.4M
% of Portfolio:0.0% ($4.4M/$17.9B)
Verve Therapeutics, Inc.
Shares:912.0K
Value:$4.2M
% of Portfolio:0.0% ($4.2M/$17.9B)
Summit Midstream Corp
Shares:58.2K
Value:$2.0M
% of Portfolio:0.0% ($2.0M/$17.9B)
Alvotech
Shares:199.7K
Value:$1.9M
% of Portfolio:0.0% ($1.9M/$17.9B)
56608A105
Shares:150.0K
Value:$1.7M
% of Portfolio:0.0% ($1.7M/$17.9B)
Prime Medicine, Inc.
Shares:750.0K
Value:$1.5M
% of Portfolio:0.0% ($1.5M/$17.9B)
Silicon Motion Technology CORP
Shares:29.3K
Value:$1.5M
% of Portfolio:0.0% ($1.5M/$17.9B)
LivaNova PLC
Shares:37.0K
Value:$1.5M
% of Portfolio:0.0% ($1.5M/$17.9B)
Janux Therapeutics, Inc.
Shares:48.0K
Value:$1.3M
% of Portfolio:0.0% ($1.3M/$17.9B)